Towards quantitative and multiplexed in vivo functional cancer genomics

Towards quantitative and multiplexed in vivo functional cancer genomics

Towards quantitative and multiplexed in vivo functional cancer genomics, Published online: 28 September 2018; doi:10.1038/s41576-018-0053-7

CRISPR–Cas genome editing and next-generation sequencing are driving advances in cancer modelling and functional cancer genomics. Their application to autochthonous mouse models of human cancer to generate and analyse multiplexed and/or combinatorial alterations in vivo is reviewed here.

from Genetics via xlomafota13 on Inoreader https://ift.tt/2P5hVDK
via IFTTT